Research ArticleArticle
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting
Lourdes M. Perez-Chada, Alison Kohn, Alice B. Gottlieb, April W. Armstrong, Lihi Eder, Philip J. Mease, Alexis Ogdie, Vibeke Strand and Joseph F. Merola
The Journal of Rheumatology March 2021, jrheum.201668; DOI: https://doi.org/10.3899/jrheum.201668
Lourdes M. Perez-Chada
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Alison Kohn
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Alice B. Gottlieb
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
April W. Armstrong
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Lihi Eder
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Philip J. Mease
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Alexis Ogdie
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Vibeke Strand
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Joseph F. Merola
As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA; A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA; A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA; A.W. Armstrong, MD, MPH, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA; A. Ogdie, MD, MSCE, Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; V. Strand, MD, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; J.F. Merola, MD, MMSc, Derpartment of Dermatology, and Department of Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA. This paper does not require institutional review board approval. Address correspondence to Dr. J.F. Merola, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115, USA. Email: jfmerola@bwh.harvard.edu.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting
Lourdes M. Perez-Chada, Alison Kohn, Alice B. Gottlieb, April W. Armstrong, Lihi Eder, Philip J. Mease, Alexis Ogdie, Vibeke Strand, Joseph F. Merola
The Journal of Rheumatology Mar 2021, jrheum.201668; DOI: 10.3899/jrheum.201668
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting
Lourdes M. Perez-Chada, Alison Kohn, Alice B. Gottlieb, April W. Armstrong, Lihi Eder, Philip J. Mease, Alexis Ogdie, Vibeke Strand, Joseph F. Merola
The Journal of Rheumatology Mar 2021, jrheum.201668; DOI: 10.3899/jrheum.201668